Clinical Trial: Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography

U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06863545) titled 'Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography' on March 03.

Brief Summary: The primary objective was to evaluate the effect of PCSK9 inhibitors in addition to the background lipid-modifying therapy (LMT), compared with standard LMT in terms of clinical outcomes in patients with coronary CT angiography (CCTA)-detected high-risk plaques.

Study Start Date: March, 2025

Study Type: INTERVENTIONAL

Condition: Coronary Artery Disease CT Angiography PCSK9 Cardiovascular Events

Intervention: DRUG: PCSK9 inhibitors and background lipid-modifying therapy ...